Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial

BACKGROUND: The prognosis for advanced hepatocellular carcinoma (HCC) remains clinically unsatisfying. Apatinib has proven to be a very effective treatment for advanced HCC in our previous retrospective study. Our aim in this study was to evaluate the efficacy, safety, and toxicity of apatinib in pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Transl Med
Main Authors: Hou, Zhenyu, Zhu, Keyun, Yang, Xuejiao, Chen, Ping, Zhang, Wei, Cui, Yunlong, Zhu, Xiaolin, Song, Tianqiang, Li, Qiang, Li, Huikai, Zhang, Ti
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576000/
https://ncbi.nlm.nih.gov/pubmed/33145266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2990
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki